Get startedLog in
    Picture of Flerie AB logo

    FLERIE — Flerie AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Kahr Bio Secures $22 Mln In Equity Funding

    Picture of Flerie AB logoFlerie AB
    09/01/2026 12:01
    Jan 9 (Reuters) - Flerie AB FLERIE.ST:

FLERIE’S PORTFOLIO COMPANY KAHR BIO PRESENTS STRONG SURVIVAL DATA FROM PHASE II TRIAL WITH DSP107 AND SECURES USD 22 MILLION IN EQUITY FUNDING

FUNDS TO SUPPORT PHASE IIB TRIAL OF DSP107 IN MSS-CRC

Source text: ID:nMFN7kX2Mg

Further company coverage: FLERIE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Flerie AB

    See all news